1887

Journal of General Virology header logo

Volume 91, Issue 8

Human cytomegalovirus UL141 promotes efficient downregulation of the natural killer cell activating ligand CD112 Free

Abstract

Human cytomegalovirus (HCMV) UL141 induces protection against natural killer cell-mediated cytolysis by downregulating cell surface expression of CD155 (nectin-like molecule 5; poliovirus receptor), a ligand for the activating receptor DNAM-1 (CD226). However, DNAM-1 is also recognized to bind a second ligand, CD112 (nectin-2). We now show that HCMV targets CD112 for proteasome-mediated degradation by 48 h post-infection, thus removing both activating ligands for DNAM-1 from the cell surface during productive infection. Significantly, cell surface expression of both CD112 and CD155 was restored when UL141 was deleted from the HCMV genome. While gpUL141 alone is sufficient to mediate retention of CD155 in the endoplasmic reticulum, UL141 requires assistance from additional HCMV-encoded functions to suppress expression of CD112.

  • Received:
  • Accepted:
  • Published Online:
SGM
Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.021931-0
2010-08-01
2024-04-16
Loading full text...

Full text loading...

/deliver/fulltext/jgv/91/8/2034.html?itemId=/content/journal/jgv/10.1099/vir.0.021931-0&mimeType=html&fmt=ahah

References

  1. Ahn K., Gruhler A., Galocha B., Jones T. R., Wiertz E. J., Ploegh H. L., Peterson P. A., Yang Y., Fruh K. 1997; The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP. Immunity 6:613–621
     [Google Scholar]
  2. Aoki J., Koike S., Ise I., Sato-Yoshida Y., Nomoto A. 1994; Amino acid residues on human poliovirus receptor involved in interaction with poliovirus. J Biol Chem 269:8431–8438
     [Google Scholar]
  3. Bachelet I., Munitz A., Mankutad D., Levi-Schaffer F. 2006; Mast cell costimulation by CD226/CD112 (DNAM-1/Nectin-2): a novel interface in the allergic process. J Biol Chem 281:27190–27196
     [Google Scholar]
  4. Bacon L., Eagle R. A., Meyer M., Easom N., Young N. T., Trowsdale J. 2004; Two human ULBP/RAET1 molecules with transmembrane regions are ligands for NKG2D. J Immunol 173:1078–1084
     [Google Scholar]
  5. Bahram S., Bresnahan M., Geraghty D. E., Spies T. 1994; A second lineage of mammalian major histocompatibility complex class I genes. Proc Natl Acad Sci U S A 91:6259–6263
     [Google Scholar]
  6. Bauer S., Groh V., Wu J., Steinle A., Phillips J. H., Lanier L. L., Spies T. 1999; Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285:727–729
     [Google Scholar]
  7. Beck S., Barrell B. G. 1988; Human cytomegalovirus encodes a glycoprotein homologous to MHC class-I antigens. Nature 331:269–272
     [Google Scholar]
  8. Biron C. A., Byron K. S., Sullivan J. L. 1989; Severe herpesvirus infections in an adolescent without natural killer cells. N Engl J Med 320:1731–1735
     [Google Scholar]
  9. Bordier C. 1981; Phase separation of integral membrane proteins in Triton X-114 solution. J Biol Chem 256:1604–1607
     [Google Scholar]
  10. Bottino C., Castriconi R., Pende D., Rivera P., Nanni M., Carnemolla B., Cantoni C., Grassi J., Marcenaro S. other authors 2003; Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule. J Exp Med 198:557–567
     [Google Scholar]
  11. Burns G. F., Triglia T., Werkmeister J. A., Begley C. G., Boyd A. W. 1985; TLiSA1, a human T lineage-specific activation antigen involved in the differentiation of cytotoxic T lymphocytes and anomalous killer cells from their precursors. J Exp Med 161:1063–1078
     [Google Scholar]
  12. Cerboni C., Mousavi-Jazi M., Linde A., Soderstrom K., Brytting M., Wahren B., Karre K., Carbone E. 2000; Human cytomegalovirus strain-dependent changes in NK cell recognition of infected fibroblasts. J Immunol 164:4775–4782
     [Google Scholar]
  13. Chalupny N. J., Sutherland C. L., Lawrence W. A., Rein-Weston A., Cosman D. 2003; ULBP4 is a novel ligand for human NKG2D. Biochem Biophys Res Commun 305:129–135
     [Google Scholar]
  14. Chalupny N. J., Rein-Weston A., Dosch S., Cosman D. 2006; Down-regulation of the NKG2D ligand MICA by the human cytomegalovirus glycoprotein UL142. Biochem Biophys Res Commun 346:175–181
     [Google Scholar]
  15. Chan G., Nogalski M. T., Yurochko A. D. 2009; Activation of EGFR on monocytes is required for human cytomegalovirus entry and mediates cellular motility. Proc Natl Acad Sci U S A 106:22369–22374
     [Google Scholar]
  16. Chapman T. L., Heikeman A. P., Bjorkman P. J. 1999; The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18. Immunity 11:603–613
     [Google Scholar]
  17. Cochrane D. 2009; Detailed characterisation of the human cytomegalovirus immune modulatory gene UL141. In Infection, Immunity and Biochemistry pp 239 Cardiff: Cardiff University;
     [Google Scholar]
  18. Cosman D., Mullberg J., Sutherland C. L., Chin W., Armitage R., Fanslow W., Kubin M., Chalupny N. J. 2001; ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity 14:123–133
     [Google Scholar]
  19. Eagle R. A., Traherne J. A., Hair J. R., Jafferji I., Trowsdale J. 2009; ULBP6/RAET1L is an additional human NKG2D ligand. Eur J Immunol 39:3207–3216
     [Google Scholar]
  20. Fuchs A., Cella M., Giurisato E., Shaw A. S., Colonna M. 2004; Cutting edge: CD96 (tactile) promotes NK cell-target cell adhesion by interacting with the poliovirus receptor (CD155. J Immunol 172:3994–3998
     [Google Scholar]
  21. Furman M. H., Dey N., Tortorella D., Ploegh H. L. 2002; The human cytomegalovirus US10 gene product delays trafficking of major histocompatibility complex class I molecules. J Virol 76:11753–11756
     [Google Scholar]
  22. Gazit R., Garty B. Z., Monselise Y., Hoffer V., Finkelstein Y., Markel G., Katz G., Hanna J., Achdout H. other authors 2004; Expression of KIR2DL1 on the entire NK cell population: a possible novel immunodeficiency syndrome. Blood 103:1965–1966
     [Google Scholar]
  23. Groh V., Rhinehart R., Randolph-Habecker J., Topp M. S., Riddell S. R., Spies T. 2001; Costimulation of CD8 αβ T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat Immunol 2:255–260
     [Google Scholar]
  24. Jones T. R., Wiertz E. J., Sun L., Fish K. N., Nelson J. A., Ploegh H. L. 1996; Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains. Proc Natl Acad Sci U S A 93:11327–11333
     [Google Scholar]
  25. Kojima H., Kanada H., Shimizu S., Kasama E., Shibuya K., Nakauchi H., Nagasawa T., Shibuya A. 2003; CD226 mediates platelet and megakaryocytic cell adhesion to vascular endothelial cells. J Biol Chem 278:36748–36753
     [Google Scholar]
  26. Lanier L. L. 2008; Up on the tightrope: natural killer cell activation and inhibition. Nat Immunol 9:495–502
     [Google Scholar]
  27. Pende D., Castriconi R., Romagnani P., Spaggiari G. M., Marcenaro S., Dondero A., Lazzeri E., Lasagni L., Martini S. other authors 2006; Expression of the DNAM-1 ligands, Nectin-2 (CD112) and poliovirus receptor (CD155), on dendritic cells: relevance for natural killer-dendritic cell interaction. Blood 107:2030–2036
     [Google Scholar]
  28. Prod'homme V., Griffin C., Aicheler R. J., Wang E. C., McSharry B. P., Rickards C. R., Stanton R. J., Borysiewicz L. K., Lopez-Botet M. other authors 2007; The human cytomegalovirus MHC class I homolog UL18 inhibits LIR-1+ but activates LIR-1− NK cells. J Immunol 178:4473–4481
     [Google Scholar]
  29. Reymond N., Imbert A. M., Devilard E., Fabre S., Chabannon C., Xerri L., Farnarier C., Cantoni C., Bottino C. other authors 2004; DNAM-1 and PVR regulate monocyte migration through endothelial junctions. J Exp Med 199:1331–1341
     [Google Scholar]
  30. Scott J. L., Dunn S. M., Jin B., Hillam A. J., Walton S., Berndt M. C., Murray A. W., Krissansen G. W., Burns G. F. 1989; Characterization of a novel membrane glycoprotein involved in platelet activation. J Biol Chem 264:13475–13482
     [Google Scholar]
  31. Shibuya A., Campbell D., Hannum C., Yssel H., Franz-Bacon K., McClanahan T., Kitamura T., Nicholl J., Sutherland G. R. other authors 1996; DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes. Immunity 4:573–581
     [Google Scholar]
  32. Shibuya K., Lanier L. L., Phillips J. H., Ochs H. D., Shimizu K., Nakayama E., Nakauchi H., Shibuya A. 1999; Physical and functional association of LFA-1 with DNAM-1 adhesion molecule. Immunity 11:615–623
     [Google Scholar]
  33. Shibuya K., Shirakawa J., Kameyama T., Honda S., Tahara-Hanaoka S., Miyamoto A., Onodera M., Sumida T., Nakauchi H. other authors 2003; CD226 (DNAM-1) is involved in lymphocyte function-associated antigen 1 costimulatory signal for naive T cell differentiation and proliferation. J Exp Med 198:1829–1839
     [Google Scholar]
  34. Stanton R. J., McSharry B. P., Rickards C. R., Wang E. C., Tomasec P., Wilkinson G. W. 2007; Cytomegalovirus destruction of focal adhesions revealed in a high-throughput Western blot analysis of cellular protein expression. J Virol 81:7860–7872
     [Google Scholar]
  35. Stanton R. J., McSharry B. P., Armstrong M., Tomasec P., Wilkinson G. W. 2008; Re-engineering adenovirus vector systems to enable high-throughput analyses of gene function. Biotechniques 45:659–668
     [Google Scholar]
  36. Stern-Ginossar N., Elefant N., Zimmermann A., Wolf D. G., Saleh N., Biton M., Horwitz E., Prokocimer Z., Prichard M. other authors 2007; Host immune system gene targeting by a viral miRNA. Science 317:376–381
     [Google Scholar]
  37. Tahara-Hanaoka S., Shibuya K., Onoda Y., Zhang H., Yamazaki S., Miyamoto A., Honda S., Lanier L. L., Shibuya A. 2004; Functional characterization of DNAM-1 (CD226) interaction with its ligands PVR (CD155) and nectin-2 (PRR-2/CD112). Int Immunol 16:533–538
     [Google Scholar]
  38. Takai Y., Ikeda W., Ogita H., Rikitake Y. 2008; The immunoglobulin-like cell adhesion molecule nectin and its associated protein afadin. Annu Rev Cell Dev Biol 24:309–342
     [Google Scholar]
  39. Tomasec P., Braud V. M., Rickards C., Powell M. B., McSharry B. P., Gadola S., Cerundolo V., Borysiewicz L. K., McMichael A. J., Wilkinson G. W. 2000; Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. Science 287:1031
     [Google Scholar]
  40. Tomasec P., Wang E. C., Davison A. J., Vojtesek B., Armstrong M., Griffin C., McSharry B. P., Morris R. J., Llewellyn-Lacey S. other authors 2005; Downregulation of natural killer cell-activating ligand CD155 by human cytomegalovirus UL141. Nat Immunol 6:181–188
     [Google Scholar]
  41. Trgovcich J., Cebulla C., Zimmerman P., Sedmak D. D. 2006; Human cytomegalovirus protein pp71 disrupts major histocompatibility complex class I cell surface expression. J Virol 80:951–963
     [Google Scholar]
  42. Ulbrecht M., Martinozzi S., Grzeschik M., Hengel H., Ellwart J. W., Pla M., Weiss E. H. 2000; Cutting edge: the human cytomegalovirus UL40 gene product contains a ligand for HLA-E and prevents NK cell-mediated lysis. J Immunol 164:5019–5022
     [Google Scholar]
  43. Wang E. C., McSharry B., Retiere C., Tomasec P., Williams S., Borysiewicz L. K., Braud V. M., Wilkinson G. W. 2002; UL40-mediated NK evasion during productive infection with human cytomegalovirus. Proc Natl Acad Sci U S A 99:7570–7575
     [Google Scholar]
  44. Wiertz E. J., Jones T. R., Sun L., Bogyo M., Geuze H. J., Ploegh H. L. 1996a; The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell 84:769–779
     [Google Scholar]
  45. Wiertz E. J., Tortorella D., Bogyo M., Yu J., Mothes W., Jones T. R., Rapoport T. A., Ploegh H. L. 1996b; Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction. Nature 384:432–438
     [Google Scholar]
  46. Wilkinson G. W., Tomasec P., Stanton R. J., Armstrong M., Prod'homme V., Aicheler R., McSharry B. P., Rickards C. R., Cochrane D. other authors 2008; Modulation of natural killer cells by human cytomegalovirus. J Clin Virol 41:206–212
     [Google Scholar]
  47. Wills M. R., Ashiru O., Reeves M. B., Okecha G., Trowsdale J., Tomasec P., Wilkinson G. W., Sinclair J., Sissons J. G. 2005; Human cytomegalovirus encodes an MHC class I-like molecule (UL142) that functions to inhibit NK cell lysis. J Immunol 175:7457–7465
     [Google Scholar]
  48. Xu Z., Jin B. 2010; A novel interface consisting of homologous immunoglobulin superfamily members with multiple functions. Cell Mol Immunol 7:11–19
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.021931-0
Loading
Human cytomegalovirus UL141 promotes efficient downregulation of the natural killer cell activating ligand CD112
J. Gen. Virol. 91, 2034 (2010); https://doi.org/10.1099/vir.0.021931-0
/content/journal/jgv/10.1099/vir.0.021931-0
/content/journal/jgv/10.1099/vir.0.021931-0
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error